Department of Pediatrics
Amy K. Keating has not added Biography.
If you are Amy K. Keating and would like to personalize this page please email our Author Liaison for assistance.
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research May, 2006 | Pubmed ID: 16675557
TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.
Advances in cancer research , 2008 | Pubmed ID: 18620092
Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.
Journal of leukocyte biology Jul, 2009 | Pubmed ID: 19386698
Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.
Blood Sep, 2009 | Pubmed ID: 19643988
Thymoma in children: report of 2 cases and review of the literature.
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society May-Jun, 2010 | Pubmed ID: 20055684
Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.
Molecular cancer therapeutics May, 2010 | Pubmed ID: 20423999
Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.
Expert opinion on therapeutic targets Oct, 2010 | Pubmed ID: 20809868
Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development.
British journal of haematology Nov, 2010 | Pubmed ID: 20813012
Constitutive induction of pro-inflammatory and chemotactic cytokines in cystathionine beta-synthase deficient homocystinuria.
Molecular genetics and metabolism Aug, 2011 | Pubmed ID: 21601502
Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age.
Pediatric blood & cancer Apr, 2013 | Pubmed ID: 22848000
Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia.
Blood Aug, 2013 | Pubmed ID: 23861246
TAM receptor tyrosine kinases: expression, disease and oncogenesis in the central nervous system.
Brain research Jan, 2014 | Pubmed ID: 24184575
MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme.
Oncotarget Mar, 2014 | Pubmed ID: 24658326
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유